We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+16.53%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$184M
AUM Growth
+$6.64M
Cap. Flow
-$8.72M
Cap. Flow %
-4.75%
Top 10 Hldgs %
35.79%
Holding
86
New
25
Increased
22
Reduced
18
Closed
18

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$3.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$3.21M
3
DHR icon
Danaher
DHR
+$2.92M
4
XLRN
Acceleron Pharma
XLRN
+$2.43M
5
ESPR
Esperion Therapeutics
ESPR
+$2.41M

Top Sells

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$6.61M
2
AGN
Allergan plc
AGN
+$6.08M
3
SPNC
Spectranetics Corp
SPNC
+$4.22M
4
SNY icon
Sanofi
SNY
+$3.59M
5
CELG
Celgene Corp
CELG
+$3.06M

Sector Composition

Rank Sector Weight
1 Healthcare 76.63%
2 Financials 2.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TDOC icon
51
Teladoc Health
TDOC
$1.25B
$1.16M 0.63%
+35,000
New +$1.15M
ASND icon
52
Ascendis Pharma A/S
ASND
$16.7B
$1.09M 0.59%
+30,000
New +$861K
MRNS
53
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1.03M 0.56%
+43,750
New +$490K
SRRA
54
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$930K 0.51%
+15,000
New +$880K
FOLD
55
DELISTED
Amicus Therapeutics
FOLD
$905K 0.49%
+60,000
New +$794K
PRTK
56
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$879K 0.48%
+35,000
New +$815K
INCY icon
57
CALL
Incyte
INCY
$24.5B
$876K 0.48%
+7,500
New +$949K
IONS icon
58
Ionis Pharmaceuticals
IONS
$9.28B
$761K 0.41%
+15,000
New +$786K
ZGNX
59
DELISTED
Zogenix, Inc.
ZGNX
$701K 0.38%
20,000
-65,000
-76% -$882K
NVCN
60
DELISTED
Neovasc Inc.
NVCN
$612K 0.33%
14
– –
EXEL icon
61
PUT
Exelixis
EXEL
$12.8B
$606K 0.33%
+25,000
New +$665K
SCYX icon
62
SCYNEXIS
SCYX
$46.9M
$603K 0.33%
3,125
+312
+11% +$47.5K
VYGR icon
63
Voyager Therapeutics
VYGR
$198M
$515K 0.28%
+25,000
New +$282K
PTCT icon
64
CALL
PTC Therapeutics
PTCT
$6.12B
$500K 0.27%
+25,000
New +$489K
AKAO
65
DELISTED
Achaogen Inc
AKAO
$479K 0.26%
30,000
-30,000
-50% -$571K
OBSV
66
DELISTED
ObsEva SA Ordinary Shares
OBSV
$407K 0.22%
50,000
+20,000
+67% +$152K
RXDX
67
CALL
DELISTED
Ignyta, Inc.
RXDX
$309K 0.17%
+25,000
New +$258K
ADAP
68
DELISTED
Adaptimmune Therapeutics
ADAP
$205K 0.11%
+25,000
New +$156K
AZN icon
69
PUT
AstraZeneca
AZN
$247B
– –
-50,000
Closed -$3.41M
BMRN icon
70
CALL
BioMarin Pharmaceuticals
BMRN
$13.4B
– –
-25,000
Closed -$2.27M
EW icon
71
Edwards Lifesciences
EW
$53.9B
– –
-22,500
Closed -$887K
MDT icon
72
Medtronic
MDT
$116B
– –
-20,000
Closed -$1.77M
MRK icon
73
CALL
Merck
MRK
$323B
– –
-104,800
Closed -$6.41M
SNY icon
74
CALL
Sanofi
SNY
$104B
– –
-15,000
Closed -$719K
SNY icon
75
Sanofi
SNY
$104B
– –
-75,000
Closed -$3.59M
1 2
3
4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q3 2017 Portfolio in Review

As of Q3 2017, Iguana Healthcare Management held 86 positions worth $184M, up 3.8% from $177M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Iguana Healthcare Management withdrew a net $8.72M in Q3 2017, closing 18 positions and reducing 18 holdings. Its most notable exit was Shire pic, an estimated $6.61M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, up from 70% a quarter earlier, followed by Financials.

Against the trend, Iguana Healthcare Management opened a new position in Bristol-Myers Squibb worth $3.51M.

  • Iguana Healthcare Management's largest Q3 2017 buy was Bristol-Myers Squibb: 55,000 shares worth $3.51M.
  • Iguana Healthcare Management added most to Biogen in Q3 2017, an estimated $3.7M increase.
  • Iguana Healthcare Management's biggest Q3 2017 reduction was Celgene Corp, cutting an estimated $3.06M.
  • Iguana Healthcare Management fully exited Shire pic in Q3 2017, selling an estimated $6.61M.
  • Iguana Healthcare Management's ten largest holdings make up 36% of its $184M portfolio in Q3 2017.
  • Iguana Healthcare Management opened 25 new positions and closed 18 in Q3 2017.
  • Iguana Healthcare Management's portfolio value rose 3.8% quarter-over-quarter to $184M.

Based on Iguana Healthcare Management's 13F filing for Q3 2017, filed 14 Nov 2017.